ライフサイエンスコーパス: angiogenic potential

1 cellular electrical resistance and increased angiogenic potential.

2 rowth and exhibited high tubulogenic but low angiogenic potential.

3 s with a high proliferative capacity and pro-angiogenic potential.

4 patients is through attenuation of platelet angiogenic potential.

5 ists to platelets decreased VEGF release and angiogenic potential.

6 emonstrated a similar impact on the platelet angiogenic potential.

7 ells (MCF-7 cells) and exhibited a decreased angiogenic potential.

8 n the presence of anticoagulants rescued the angiogenic potential.

9 ated patients had decreased VEGF release and angiogenic potential.

10 Human recombinant CAGE protein displayed angiogenic potential.

11 as the invasion, tumorigenic potential, and angiogenic potential.

12 own to regulate eosinophil viability and pro-angiogenic potential.

13 ogenic potential, and enhance their inherent angiogenic potential.

14 reatment significantly decreased endothelial angiogenic potential.

15 lar matrix (ECM) remodeling and insufficient angiogenic potential.

16 ent and -independent cell growth and reduced angiogenic potential.

17 ed SDF1-mediated in vitro cell migration and angiogenic potential.

18 c agents have been developed which have anti-angiogenic potential.

19 cal for AdE4(+)-mediated survival of ECs and angiogenic potential.

20 ptosis and reduce both cellular invasion and angiogenic potential.

21 lost their ability to invade and had reduced angiogenic potential.

22 proliferation of HMEC-1, thus demonstrating angiogenic potential.

23 e of genetic factors that control individual angiogenic potential.

24 nt conditioned medium (CM) was evaluated for angiogenic potential and for expression of angiogenic fa

25 The VHL gene has been shown to regulate angiogenic potential and glycolic metabolism via its E3

26 rs implicated in cancer stemness with higher angiogenic potential and tumorigenicity.

27 herapeutic target and indicator of a tumor's angiogenic potential, and enables predictions that are s

28 st myogenic differentiation potency, highest angiogenic potential, and relatively high production of

29 es and NSCLC cells synergistically increases angiogenic potential, and that this is due to an increas

30 tion, we demonstrate that A(2A) receptor has angiogenic potential, as assessed by increases in cell p

31 erminal 20 peptide (PAMP), exhibits a potent angiogenic potential at femtomolar concentrations, where

32 the vascular nodules resulted in the loss of angiogenic potential both in vitro and in vivo in the ch

33 l line that lacks osteogenic, adipogenic and angiogenic potential but is capable of differentiation t

34 with reduced tumor immunosuppression and neo-angiogenic potential by TAMs, MIF deficiency confers pro

35 -mobilized blood displayed increased in vivo angiogenic potential compared with AMD3100-mobilized CAC

36 mice developed normally, but showed enhanced angiogenic potential compared with TbetaRII(endo+/+) mic

37 Decreased angiogenic potential could contribute to the development

38 e conditions, while preserving their in vivo angiogenic potential for tubulogenesis and sprouting.

39 /NF90 isoform showed reduced tumorigenic and angiogenic potential in an orthotopic breast tumor model

40 ntravasation, PC-hi/diss exhibited increased angiogenic potential in avian and murine models.

41 EGF mRNA nor protein is an adequate index of angiogenic potential in response to ischaemia.

42 Despite an increased angiogenic potential in Sh2b3(em2Mcwi) rats (1.7-fold; P

43 with 4F decreases inflammation and restores angiogenic potential in Tsk(-/+) hearts.

44 the V659E transfectants paralleled increased angiogenic potential in vitro.

45 henotype and that these cells maintain their angiogenic potential in vitro.

46 enhanced motility and invasion in vitro and angiogenic potential in vivo.

47 antability of tumor stroma suggests that the angiogenic potential of a tumor xenograft, which determi

48 After angiogenesis blockade in vivo, the angiogenic potential of atherosclerotic tissue is suppre

49 We compared the angiogenic potential of bone marrow plasma and the expre

50 We also assayed the angiogenic potential of cytotrophoblast-derived factors

51 eceptor, GPR4, as critical regulators of the angiogenic potential of EC.

52 dE4+) selectively modulates the survival and angiogenic potential of ECs by as of yet unrecognized me

53 infection with AdE4(+) vectors increased the angiogenic potential of ECs by promoting EC migration an

54 beta 8 (ITGbeta8)-2 genes essential for the angiogenic potential of ECs-as targets of miR-143 and mi

55 We investigated the angiogenic potential of EMC10 and its mouse homolog (Emc

56 ve shown that VEGF enhances the survival and angiogenic potential of endothelial cells by activating

57 expression and caused marked decrease in the angiogenic potential of endothelial cells without affect

58 ncentrations of AT101 potently inhibited the angiogenic potential of endothelial cells.

59 We have previously reported that the angiogenic potential of highly proliferative endothelial

60 via thermal oxidation method to enhance the angiogenic potential of human umbilical vein endothelial

61 ession of RPS15A in Huh7 cells increased the angiogenic potential of HUVEC in a paracrine fashion; co

62 24 plays an essential role in modulating the angiogenic potential of microvascular ECs by regulating

63 vailable living cellular sheets (LCS) on the angiogenic potential of neonatal dermal human microvascu

64 Vascular size and irregularity reflect the angiogenic potential of prostate cancer and may serve as

65 lin significantly decreased the survival and angiogenic potential of radioresistant lung cancer cells

66 This corresponded to an increased angiogenic potential of serum from patients with LVADs (

67 Tumorigenic and angiogenic potential of the clones was studied by inject

68 in due to aberrant bleeding could affect the angiogenic potential of the endometrium, creating a feed

69 cused on the role of ZNF24 in modulating the angiogenic potential of the endothelial compartment.

70 ression of VEGF expression and inhibition of angiogenic potential of these carcinoma cells.

71 This report illustrates the anti-angiogenic potential of these ribozymes as well as their

72 markedly different, suggesting distinct pro-angiogenic potential of these stem cell derivatives.

73 ular tissues, and analyzed the mitogenic and angiogenic potential of this eicosanoid.

74 r, these studies highlight a key role of pro-angiogenic potential of transplanted osteogenic cells fo

75 es in KSHV-induced angiogenesis and that the angiogenic potential of vGPCR might also be due to its a

76 s-induced paracrine angiogenic capacity (the angiogenic potential) of cardiomyocytes.

77 osteogenic progenitor cells with higher pro-angiogenic potential significantly enhance bone repair i

78 AKT (LY294002) and PKR (C16) disrupted their angiogenic potentials, suggesting that RNF213 and its up

79 elial cells that overexpress Bcl-2 have more angiogenic potential than control cells, and IL-8-neutra

80 Because CEPC numbers correlate with angiogenic potential, this suggests that variant Adam17

81 sly implicated in sprout guidance, represses angiogenic potential to ensure the proper abundance and

82 itioned by MCT-1-negative cells restored its angiogenic potential to that of the MCF7-MCT-1 cells.

83 ese properties confer a significantly higher angiogenic potential to VEGF111 in comparison with the o

84 The iVPCs demonstrated better in vitro angiogenic potential (tube network on 2-dimensional cult

85 etinal endothelial cell barrier function and angiogenic potential via activation of oxidative stress.

86 Bone marrow angiogenic potential was studied using a human in vitro

87 l cell chemotactic activity (as a measure of angiogenic potential) was significantly increased in res